Recent advances: Care of near term infants with respiratory failure

British Medical Journal

Volumn 315, Issue 7117, 1997, Pages 1215-1218

  Barrington, Keith J ^a   Finer, Neil N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; LUNG SURFACTANT; NITRIC OXIDE; SURFACTANT;

ARTICLE; EXTRACORPOREAL OXYGENATION; HIGH FREQUENCY VENTILATION; HUMAN; INFANT; INFANT MORTALITY; LUNG HYPOPLASIA; MECONIUM ASPIRATION; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RESPIRATORY FAILURE;

EID: 0030662023     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7117.1215     Document Type: Article

References (38)

1. Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB. Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 1985;76:479-87.
2. O'Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, et al. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics 1989;84:957-63.
3. Stolar CJH, Snedecor SM, Bartlett RH, Extracorporeal membrane oxygenation and neonatal respiratory failure: experience from the extracorporeal life support orgainzation. J Pediatr Surg 1991;26:563-71.
4. UK Collaborative ECMO Trial Group. UK collaborative tandomised trial of neonatal extracorporeal membrane oxygenation. Lancet 1996;348:75-82.
5. Delius R, Anderson H, Schumacher R, Shapiro M, Otsu T, Toft K, et al. Venovenous compares favorably with venoarterial access for extracorporeal membrane oxygenation in neonatal respiratory failure. J Thorac Cardiovasc Surg 1993;106:329-38.
6. Cornish JD, Heiss KF, Clark RH, Strieper MJ, Boecker B, Kesser K. Efficacy of venovenous extracorporeal membrane oxygenation for neonates with respiratory and circulatory compromise. J Peditar 1993;122:105-9.
7. Durandy Y, Chevalier JY. Single-cannula venovenous bypass for respiratory membrane lung support. J Thorac Cardiovasc Surg 1990;99:404-9.
8. Moncada S. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992;145:201-7.
9. Etches P, Finer NN, Barrington KJ, Graham AJ, Chan WK. Nitric oxide-reverses acute hypoxic pulmonary hypertension in the newborn piglet. Pediatr Res 1994;35:15-9.
10. Barrington KJ, Finer NN, Peliowski A, Etches PC, Graham AJ, Chan WKY. Inhaled nitric oxide improves oxygenation in a piglet model of ineconium aspiration. Pediatr Pulmonol 1995;20:27-33.
11. North American Inhaled Nitric Oxide (NINOS) Study Group. Inhaled nitric oxide in term and near-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604.
12. North American Inhaled Nitric Oxide (NINOS) Study Group. Inhaled nitric oxide in near-term infants with congenital diaphragmatic hernia. Pediatrics 1997;99:838-45
13. Roberts JD Jr, Fineman J, Morin FC III, Shaul PW, Rimar S, Schreiber MD, et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med 1997;336:605-10.
14. Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Clark RH, et al. Randomized, multicenter trial of inhaled nitric oxide and high frequency ventilation in severe persistent pulmonary hypertension of the newborn. Pediatr Res 1996;39:222A.
15. Day RW, Lynch JM, White KS, Ward RM. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics 1996;98:698-705.
16. Barefield ES, Karke VA, Phillips JH, Carlo WA. Inhaled nitric oxide in term infants with hypoxemic respiratory failure. J Pediatr 1996;129:279-86.
17. Wessel D, Agatia I, Thompson J, Kane J, Van Marter L, Stark A, et al. Improved oxygenation in a randomized trial of inhaled nitric oxide for PPHN. Pediatr Res 1996;39:252A.
18. Barrington KJ, Finer NN. Inhaled nitric oxide for the hypoxic near term neonate. Cochranc Database of Systematic Reviews (in press).
19. Hogman M, Frostell C, Arnberg H, Sandhagen B, Hedenstierna G. Prolonged bleeding time during nitric oxide inhalation in the rabbit. Acta Physiol Scand 1994;151:125-9.
20. Rossaint R, Falke KJ, Lopez F, Slaina K, Pison U, Zapol WM. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med 1993;328:399-405.
21. Zwissler B, Kemming G, Habler O, Kleen M, Merkel M, Haller M, et al. Inhaled prostacyclin (PG1(2)) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:1671-7.
22. Vane JR, Botting RM, Pharmacodynamic profile of prostayclin. Am J Cardiol 1995;75:3-10A.
23. Clark DA, Nieman GF, Thompson JE, Paskanik AM, Rokhar JE, Bredenberg CE. Surfactant displacement by meconium free fatty acids: an alternative explanation for atelectasis in meconium aspiration syndrome. J Pediatr 1987;110:765-70.
24. Sun B, Curstedt T, Robertson B. Surfactant inhibition in experimental meconiuni aspiration. Acta Paediatr 1993;82:182-9.
25. Song GW, Robertson B, Curstedt T, Gan XZ, Huang WX. Surfactant treatment in experimental Escherichia coli pneumonia. Acta Anaesthesiol Scand 1996;40:1154-60.
26. Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M, Rubens CE. Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immunol 1996;64:3818-26.
27. Glick PL, Stannard VA, Leach CL, Rossman J, Hosada Y, Morin FC, et al. Pathophysiology of congenital diaphragmatic hernia. II. The fetal lamb CDH model is surfactant deficient. J Pediatr Surg 1992;27:382-7.
28. Nakamura Y, Yamamoto I, Funatsu Y, Motomura K, Fukuda S. Decreased surfactant level in the lung with oligohydramnios: a morphometric and biochemical study. J Pediatr 1988;112:171-4.
29. Findlay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconiuin aspiration syndrome. Pediatrics 1996;97:18-52.
30. Lotze A, Knight GR, Martin GR, Bulas DI, Hull WM, O'Donnell RM, et al. Improved pulmonary outcome atter exogenous surfactant therapy for respiratory failure in term infants requiring extracorporeal membrane oxygenation. J Pediatr 1993;122:261-8.
31. Lotze A, Survanta in Term Infants Study Group. Survanta pre-ecmo trial: multicenter evaluation of survanta in treatment of term infants with severe respiratory failure. Pediatr Res 1996;39:226A.
32. Froese AB, Bryan AC. High frequency ventilation. Am Rev Respir Dis 1987;135:1363-74.
33. Clark RH, Yoder BA, Sell MS. Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation. J Pediatr 1994;124:447-54.
34. Wiswell TE, Grazizni LJ, Kornhauser MS, Cullen J, Merton DA, McKee L, et al. High-frequency jet ventilation in the early management of respiratory distress syndrome is associated with a greater risk for adverse outeomes, Pediatrics 1996;98:1035-43.
35. Fuhrman BP. Perfluorocarbon liquids and respiratory support. Crit Care Med 1993;21:951.
36. Wolfson MR, Greenspan JS, Shafler TH. Pulmonary administration of vasoactive substances by perfluorocheinical ventilation. Pediatrics 1996;97:149-55.
37. Leach CL, Greenspan JS, Rubenstein SD, Shafler TH, Wolfson MR, Jackson JC, et al. Partial liquid ventilation with perflubron in premature infants with severe respiratory distress syndrome. The LiquiVent Study Group. N Engl J Med 1996;335:761-7.
38. Zhang S, Garbutt V, McBride JT. Strain-induced growth of the immature lung. J Appl Physiol 1996;81:1471-6.